Shacey Petrovic - Aug 31, 2021 Form 4 Insider Report for INSULET CORP (PODD)

Signature
/s/ John W. Kapples, attorney-in-fact
Stock symbol
PODD
Transactions as of
Aug 31, 2021
Transactions value $
-$3,794,334
Form type
4
Date filed
10/4/2021, 04:13 PM
Previous filing
Jul 2, 2021
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PODD Common Stock Gift $0 -18.6K -21.25% $0.00 68.9K Aug 31, 2021 By NG Trust
transaction PODD Common Stock Gift $0 +18.6K +71.79% $0.00 44.5K Aug 31, 2021 By SP Trust
transaction PODD Common Stock Gift $0 -38.1K -85.62% $0.00 6.4K Aug 31, 2021 By SP Trust
transaction PODD Common Stock Options Exercise $227K +7.44K +47.13% $30.58* 23.2K Oct 1, 2021 Direct F1
transaction PODD Common Stock Options Exercise $221K +7.56K +32.58% $29.26* 30.8K Oct 1, 2021 Direct F1
transaction PODD Common Stock Sale -$4.24M -15K -48.73% $282.87 15.8K Oct 1, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PODD Employee Stock Option (Right to Buy) Options Exercise $0 -7.44K -100% $0.00* 0 Oct 1, 2021 Common Stock 7.44K $30.58 Direct F3
transaction PODD Employee Stock Option (Right to Buy) Options Exercise $0 -7.56K -16.95% $0.00 37.1K Oct 1, 2021 Common Stock 7.56K $29.26 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
F2 The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $278.50 to $287.67. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3 This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
F4 This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.